デフォルト表紙
市場調査レポート
商品コード
1764130

ステント市場-世界の産業規模、シェア、動向、機会、予測、製品タイプ別、最終用途別、地域別、競合別、2020～2030年

Stent Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End Use, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
ステント市場-世界の産業規模、シェア、動向、機会、予測、製品タイプ別、最終用途別、地域別、競合別、2020～2030年
出版日: 2025年06月30日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

世界のステント市場は、2024年に150億4,000万米ドルと評価され、2030年には347億5,000万米ドルに達し、CAGR 4.38%で成長すると予測されています。

ステントは、狭くなったり弱くなったりした動脈を補強するために使用される小さなメッシュチューブで、冠動脈疾患や末梢動脈疾患などの心血管疾患の管理に重要な役割を果たしています。糖尿病、高血圧、肥満など、動脈閉塞のリスクを高める生活習慣に関連した健康状態の有病率の増加により、市場は拡大しています。高齢者の増加と座りっぱなしの生活スタイルへの世界のシフトに伴い、ステント留置術の需要は増加の一途をたどっています。この急増は、人口動態が高齢化している先進国でも、急速な都市化とヘルスケアの進化を経験している市場でも顕著です。しかし、この市場は、特に資源が限られた環境では先進的なステント技術のコストが高く、規制が複雑なため新しいイノベーションの採用が遅れる可能性があるなどのハードルに直面しています。

市場概要
予測期間 2026～2030年
市場規模：2024年 150億4,000万米ドル
市場規模：2030年 347億5,000万米ドル
CAGR：2025～2030年 4.38%
急成長セグメント 薬剤溶出ステント
最大市場 北米

市場促進要因

ヘルスケア産業の成長

主要市場課題

ステントへのアクセス制限

主要市場動向

3Dプリンティングステントの開発拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のステント市場に与える影響

第5章 世界のステント市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品タイプ別（薬剤溶出ステント、ベアメタル冠動脈ステント、生体吸収性ステント、その他）
    • 最終用途別（病院クリニック、外来手術センター、その他）
    • 地域別
    • 企業別（2024年）
  • 市場マップ

第6章 北米のステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋のステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 世界のステント市場：SWOT分析

第15章 ポーターのファイブフォース分析

  • 産業内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Medtronic plc
  • B. Braun Melsungen AG
  • Terumo Corporation
  • STENTYS SA
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd
  • Translumina GmbH
  • Biosensors International Group Limited
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG

第17章 戦略的提言

第18章 調査会社について・免責事項

目次
Product Code: 5006

The Global Stent Market was valued at USD 15.04 Billion in 2024 and is projected to reach USD 34.75 Billion by 2030, growing at a CAGR of 4.38%. Stents are small mesh tubes used to reinforce narrowed or weakened arteries, playing a critical role in managing cardiovascular and vascular conditions such as coronary artery disease and peripheral artery disease. The market is expanding due to the increasing prevalence of lifestyle-related health conditions-such as diabetes, hypertension, and obesity-that heighten the risk of arterial blockages. With a rising geriatric population and the global shift toward sedentary lifestyles, the demand for stenting procedures continues to grow. This surge is evident in both developed countries with aging demographics and emerging markets experiencing rapid urbanization and healthcare evolution. However, the market faces hurdles including the high cost of advanced stent technologies, especially in resource-limited settings, and regulatory complexities that may slow the adoption of newer innovations.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 15.04 Billion
Market Size 2030USD 34.75 Billion
CAGR 2025-20304.38%
Fastest Growing SegmentDrug-Eluting Stent
Largest MarketNorth America

Key Market Drivers

Growth in Healthcare Industry

The expansion of the global healthcare sector, which generates over USD 4 trillion annually, is significantly influencing the growth of the stent market. Key segments such as pharmaceuticals, biotechnology, medical technology, and diagnostics contribute hundreds of billions in revenue and are central to the rising demand for advanced treatment solutions. As investments in healthcare infrastructure increase worldwide, so does access to cutting-edge cardiovascular care. Public and private healthcare spending has enabled better-equipped hospitals, improved interventional cardiology services, and wider availability of diagnostic tools. Cardiovascular diseases, responsible for around 17.9 million deaths globally each year, remain the leading cause of mortality. Over 80% of these are due to heart attacks and strokes, with nearly one-third of cases occurring prematurely in people under 70. Stents are a standard component in the treatment of these conditions, particularly in angioplasty procedures. The adoption of advanced technologies and minimally invasive interventions has contributed to the widespread use of stents in both high-income and developing nations.

Key Market Challenges

Limited Accessibility of Stents

Limited accessibility to stents poses a significant challenge, particularly in low- and middle-income regions. Although technological advancements have made stent procedures more effective and less invasive, access remains uneven. Many patients in under-resourced areas encounter financial and infrastructural barriers that prevent them from receiving timely and effective treatment. A primary constraint is the high cost associated with advanced stents, including drug-eluting and bioabsorbable variants, which often exceed the budget of public healthcare systems in these regions. Costs extend beyond the devices themselves to include diagnostics, surgery, hospitalization, and post-operative care. In countries where insurance coverage is limited and public subsidies are scarce, patients are frequently left with few options-either forgoing treatment or settling for outdated or substandard alternatives.

Key Market Trends

Growing Development of 3D-Printed Stents

The development of 3D-printed stents marks a significant innovation in the stent market, driven by the need for personalized treatment and advancements in additive manufacturing. Unlike traditional stents, which come in standardized forms, 3D printing allows for custom-designed stents tailored to a patient's exact anatomical structure. This customization leads to improved placement accuracy, better clinical outcomes, and fewer complications such as restenosis or stent malapposition. A notable example includes patient-specific stents created at the Cleveland Clinic using CT imaging and proprietary 3D visualization software, where 3D-printed molds are used to shape medical-grade silicone. These personalized devices ensure a precise fit and highlight the potential of 3D printing to revolutionize cardiovascular care.

Key Market Players

  • Medtronic plc
  • B. Braun Melsungen AG
  • Terumo Corporation
  • STENTYS SA
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd
  • Translumina GmbH
  • Biosensors International Group Limited
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG

Report Scope

In this report, the Global Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Stent Market, By Product Type:

  • Drug-Eluting Stent
  • Bare Metal Coronary Stent
  • Bioabsorbable Stent
  • Others

Stent Market, By End Use:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Stent Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Stent Market.

Available Customizations

Global Stent Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Stent Market

5. Global Stent Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, Bioabsorbable Stent, Others)
    • 5.2.2. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Stent Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Stent Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Stent Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Stent Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End Use

7. Europe Stent Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Stent Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Stent Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Stent Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Stent Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Stent Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End Use

8. Asia Pacific Stent Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Stent Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Stent Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Stent Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Stent Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Stent Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End Use

9. South America Stent Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Stent Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Stent Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Stent Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Stent Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Stent Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Stent Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Stent Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Stent Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Medtronic plc
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. B. Braun Melsungen AG
  • 16.3. Terumo Corporation
  • 16.4. STENTYS SA
  • 16.5. MicroPort Scientific Corporation
  • 16.6. Meril Life Sciences Pvt. Ltd
  • 16.7. Translumina GmbH
  • 16.8. Biosensors International Group Limited
  • 16.9. Boston Scientific Corporation
  • 16.10. BIOTRONIK SE & Co. KG

17. Strategic Recommendations

18. About Us & Disclaimer